ArticleOncogene2021

A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers.

Sarkis Hamalian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.